Status:
COMPLETED
Influence of Plantago Major on Mineral Metabolism and Selected Biochemical Parameters in Obese Women
Lead Sponsor:
Poznan University of Life Sciences
Collaborating Sponsors:
Poznan University of Medical Sciences
Conditions:
Obesity
Eligibility:
FEMALE
18-60 years
Phase:
NA
Brief Summary
Effect of oral supplementation with Plantago major on cardiometabolic risk factors and mineral content and lifestyle in obese women: double-blind, randomized clinical trial.
Detailed Description
The purpose of the study is to determine whether oral Plantago major supplementation affects cardiometabolic risk factors, mineral content, and lifestyle in obese women. In previous research it was f...
Eligibility Criteria
Inclusion
- body mass index (BMI) equal to or greater than 30 kg/m2
- age 18 to 60 years
- stable body weight (\< 3 kg self-reported change during the previous three months)
- written informed consent to participate in the study,
- abdominal obesity - waist circumference\> 80 cm;
- body fat content measured by bio-impedance ≥ 33%;
- female
Exclusion
- secondary obesity or secondary hypertension
- diabetes type I
- gastrointestinal disease;
- dyslipidaemia, type 2 diabetes, hypertension requiring the implementation of pharmacological treatment in the last 3 months prior to observation or follow-up;
- a history of use of any dietary supplements within the one month prior to the study
- clinically significant acute or chronic inflammatory disease in the respiratory, gastrointestinal or genitourinary system or in the mouth, throat, paranasal sinuses and / or connective tissue disease, arthritis;
- simultaneous participation in a study that affects body mass or use of diet / medication / nutritional behaviors affecting body mass;
- a history of infection in the month prior to the study
- nicotine, drug or alcohol abuse
- or other condition that, in the opinion of the investigators, would make participation not in the best interest of the patient or could prevent, limit, or confound the study results
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2021
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT03439540
Start Date
March 1 2018
End Date
September 30 2021
Last Update
April 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Poznan University of Life Sciences
Poznan, Poland, 60-624